Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.19.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2019
Dec. 31, 2018
Current assets:    
Cash and cash equivalents $ 56,168 $ 60,698
Short-term investments 181,377 248,933
Restricted cash - short-term 194 194
Prepaid expenses and other current assets 13,091 11,664
Total current assets 250,830 321,489
Property and equipment, net 58,119 68,576
Operating lease assets 14,041  
Restricted cash - long-term 1,200 1,200
Other assets 536 574
Total assets 324,726 391,839
Current liabilities:    
Accounts payable 6,168 3,719
Accrued compensation 7,459 10,636
Accrued research and development expenses 6,194 19,210
Other current liabilities 5,354 6,414
Total current liabilities 25,175 39,979
Operating lease liabilities - long-term 14,437 0
Other long-term liabilities 1,180 13,003
Total liabilities 40,792 52,982
Commitments and contingencies (Note 8)
Stockholders’ equity:    
Common stock—$0.0001 par value, 500,000 shares authorized as of March 31, 2019 and December 31, 2018; 46,307 and 45,951 shares issued and outstanding as of March 31, 2019 and December 31, 2018, respectively 5 5
Additional paid-in capital 877,133 866,541
Accumulated other comprehensive income (loss) 38 (340)
Accumulated deficit (593,242) (527,349)
Total stockholders’ equity 283,934 338,857
Total liabilities and stockholders’ equity $ 324,726 $ 391,839